212 related articles for article (PubMed ID: 21498637)
1. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.
Wozniak KM; Nomoto K; Lapidus RG; Wu Y; Carozzi V; Cavaletti G; Hayakawa K; Hosokawa S; Towle MJ; Littlefield BA; Slusher BS
Cancer Res; 2011 Jun; 71(11):3952-62. PubMed ID: 21498637
[TBL] [Abstract][Full Text] [Related]
2. Neuropathy-inducing effects of eribulin mesylate versus paclitaxel in mice with preexisting neuropathy.
Wozniak KM; Wu Y; Farah MH; Littlefield BA; Nomoto K; Slusher BS
Neurotox Res; 2013 Oct; 24(3):338-44. PubMed ID: 23637052
[TBL] [Abstract][Full Text] [Related]
3. Differential Morphological and Biochemical Recovery from Chemotherapy-Induced Peripheral Neuropathy Following Paclitaxel, Ixabepilone, or Eribulin Treatment in Mouse Sciatic Nerves.
Cook BM; Wozniak KM; Proctor DA; Bromberg RB; Wu Y; Slusher BS; Littlefield BA; Jordan MA; Wilson L; Feinstein SC
Neurotox Res; 2018 Oct; 34(3):677-692. PubMed ID: 30051419
[TBL] [Abstract][Full Text] [Related]
4. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
LaPointe NE; Morfini G; Brady ST; Feinstein SC; Wilson L; Jordan MA
Neurotoxicology; 2013 Jul; 37():231-9. PubMed ID: 23711742
[TBL] [Abstract][Full Text] [Related]
5. Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
Wozniak KM; Vornov JJ; Wu Y; Nomoto K; Littlefield BA; DesJardins C; Yu Y; Lai G; Reyderman L; Wong N; Slusher BS
Cancer Res; 2016 Jun; 76(11):3332-9. PubMed ID: 27197173
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs.
Smith JA; Slusher BS; Wozniak KM; Farah MH; Smiyun G; Wilson L; Feinstein S; Jordan MA
Cancer Res; 2016 Sep; 76(17):5115-23. PubMed ID: 27488522
[TBL] [Abstract][Full Text] [Related]
7. Effects of Paclitaxel and Eribulin in Mouse Sciatic Nerve: A Microtubule-Based Rationale for the Differential Induction of Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Cook BM; Reifert J; Wozniak KM; Slusher BS; Littlefield BA; Wilson L; Jordan MA; Feinstein SC
Neurotox Res; 2016 Feb; 29(2):299-313. PubMed ID: 26659667
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery.
Wozniak KM; Vornov JJ; Wu Y; Liu Y; Carozzi VA; Rodriguez-Menendez V; Ballarini E; Alberti P; Pozzi E; Semperboni S; Cook BM; Littlefield BA; Nomoto K; Condon K; Eckley S; DesJardins C; Wilson L; Jordan MA; Feinstein SC; Cavaletti G; Polydefkis M; Slusher BS
Cancer Res; 2018 Feb; 78(3):817-829. PubMed ID: 29191802
[TBL] [Abstract][Full Text] [Related]
9. Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.
Benbow SJ; Wozniak KM; Kulesh B; Savage A; Slusher BS; Littlefield BA; Jordan MA; Wilson L; Feinstein SC
Neurotox Res; 2017 Jul; 32(1):151-162. PubMed ID: 28391556
[TBL] [Abstract][Full Text] [Related]
10. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
[TBL] [Abstract][Full Text] [Related]
11. Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.
Vahdat LT; Garcia AA; Vogel C; Pellegrino C; Lindquist DL; Iannotti N; Gopalakrishna P; Sparano JA
Breast Cancer Res Treat; 2013 Jul; 140(2):341-51. PubMed ID: 23877339
[TBL] [Abstract][Full Text] [Related]
12. Schedule dependency of paclitaxel-induced neuropathy in mice: a morphological study.
Mimura Y; Kato H; Eguchi K; Ogawa T
Neurotoxicology; 2000 Aug; 21(4):513-20. PubMed ID: 11022860
[TBL] [Abstract][Full Text] [Related]
13. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.
Cavaletti G; Cavalletti E; Montaguti P; Oggioni N; De Negri O; Tredici G
Neurotoxicology; 1997; 18(1):137-45. PubMed ID: 9215996
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.
Goel S; Mita AC; Mita M; Rowinsky EK; Chu QS; Wong N; Desjardins C; Fang F; Jansen M; Shuster DE; Mani S; Takimoto CH
Clin Cancer Res; 2009 Jun; 15(12):4207-12. PubMed ID: 19509177
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
[TBL] [Abstract][Full Text] [Related]
16. Eribulin mesylate.
Jain S; Vahdat LT
Clin Cancer Res; 2011 Nov; 17(21):6615-22. PubMed ID: 21859830
[TBL] [Abstract][Full Text] [Related]
17. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats.
Pourmohammadi N; Alimoradi H; Mehr SE; Hassanzadeh G; Hadian MR; Sharifzadeh M; Bakhtiarian A; Dehpour AR
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):231-7. PubMed ID: 21917116
[TBL] [Abstract][Full Text] [Related]
18. Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.
Cortes J; Montero AJ; Glück S
Cancer Treat Rev; 2012 Apr; 38(2):143-51. PubMed ID: 21550727
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Vahdat LT; Pruitt B; Fabian CJ; Rivera RR; Smith DA; Tan-Chiu E; Wright J; Tan AR; Dacosta NA; Chuang E; Smith J; O'Shaughnessy J; Shuster DE; Meneses NL; Chandrawansa K; Fang F; Cole PE; Ashworth S; Blum JL
J Clin Oncol; 2009 Jun; 27(18):2954-61. PubMed ID: 19349550
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective interactions in rats between paclitaxel and cisplatin.
McKeage MJ; Haddad GG; Ding L; Galettis P; Screnci D; Zhuang L; Baguley BC
Oncol Res; 1999; 11(6):287-93. PubMed ID: 10691031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
